Are we getting closer to prevention and treatment of corneal neovascularization?

Clin Exp Ophthalmol. 2007 Nov;35(8):689-90. doi: 10.1111/j.1442-9071.2007.01616.x.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use*
  • Animals
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Corneal Neovascularization / prevention & control*
  • Humans
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Vascular Endothelial Growth Factor A
  • Bevacizumab